![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Reports Appointment of Steve Gorlin as a Director and Designation of David J. Drutz as President and Chief Executive Officer
December 20, 2011 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Dec. 20, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) reported today that Steve Gorlin has been appointed to fill a vacancy on the Company's Board of Directors. Mr....
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Reports Management Changes
December 07, 2011 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Dec. 7, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) reported today that Richard A. Franco, Sr. will retire as Chairman, President and Chief Executive Officer and as a...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
Five New U.S. and Foreign Patents Have Been Granted to DARA BioSciences, Inc.
November 08, 2011 08:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Nov. 8, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) today announced that five new patents were granted in the United States, Asia and Israel for its drug development...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Selected to Present at Conferences
November 02, 2011 08:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Nov. 2, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the Company has been selected to present at the following upcoming conferences.
Landmark...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Announces Positive Results From a Successfully Completed Phase 1b Clinical Study of DB959 for the Treatment of Type 2 Diabetes
November 01, 2011 08:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Nov. 1, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), announces the positive results from a successfully completed Phase 1b clinical study for DB959, its peroxisome...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
KRN5500 Demonstrated Significant Decrease in the Intensity of Neuropathic Pain in Patients with Cancer, According to Findings Published in the Journal of Pain and Symptom Management
October 10, 2011 10:57 ET
|
DARA BioSciences, Inc.
"A Spicamycin Derivative (KRN5500) Provides Neuropathic Pain Relief in Patients with Advanced Cancer: A Placebo-Controlled, Proof-of-Concept Trial"
RALEIGH, N.C., Oct. 10, 2011 (GLOBE NEWSWIRE) --...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Selected to Present the Positive Results of KRN5500 Phase 2 Study at the 5th Annual Therapeutics Summit
September 15, 2011 09:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 15, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the Company has been selected to present the positive clinical data results for KRN5500, its...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences to Present at Rodman & Renshaw Annual Global Healthcare Investment Conference
September 06, 2011 09:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 6, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that Richard A. Franco, R.Ph., Chief Executive Officer and President, is scheduled to present at...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Receives Fast Track Designation From the U.S. FDA for KRN5500 for the Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer
August 18, 2011 09:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Aug. 18, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that its investigational drug KRN5500 has been granted Fast Track designation by the U.S. Food and...
![DARA BioSciences, Inc. Logo](/news-release/logo/217527/0/217527.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A34&size=2)
DARA BioSciences Files Quarterly Report With the SEC and Issues Overview of First Six Months
August 16, 2011 09:00 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Aug. 16, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) a pharmaceutical drug development company, highlights a number of achievements disclosed in the Company's...